Global Advanced Drug Delivery CDMO Market Size is predicted to show a 5.0% CAGR during the forecast period for 2025-2034.
The pharmaceutical sector greatly benefits from a Contract Development and Manufacturing Organisation (CDMO) specialising in cutting-edge drug delivery technologies. These CDMOs offer services for creating, formulating, and developing drug delivery systems beyond conventional oral tablets or capsules. Modern medication delivery systems have arisen as a quick and precise way to get the drug to the right place. These systems have several advantages over conventional systems, including the focused and regulated delivery of novel molecules to target areas, consistent drug absorption, reduced frequency of dosing, decreased production of hazardous metabolites, and lower variability in systemic drug concentrations.
The need for advanced drug delivery CDMOs has increased as a result of improved drug performance and superior results brought about by advanced drug delivery systems. However, the Advanced Drug Delivery Contract Development and Manufacturing Organisation (CDMO) market was significantly impacted by the COVID-19 pandemic, which had a wide-ranging effect on the sector. The pandemic affected the availability of raw materials and parts needed for medicine delivery systems by upsetting global supply chains. For several CDMOs, this resulted in manufacturing difficulties and delivery delays.
Some Major Key Players in the Advanced Drug Delivery CDMO Market are:
The advanced drug delivery CDMO market is segmented on the basis of services which is segmented as service type, technology, dosage form, application and end-user. Based on the service type, the market segmented into formulation development, process development and scale-up, analytical and testing services, manufacturing services, packaging and, device development, regulatory support. Based on the technology, the market segmented into targeted drug delivery systems, controlled/sustained-release technologies, injectable delivery platforms, pulmonary & nasal delivery systems, transdermal & microneedle delivery, mucosal delivery methods, implantable delivery devices, 3d-printed drug delivery. Based on the dosage form, the market segmented into injectables, oral solids, topical & transdermal, implantables & ocular. Based on the application, the market segmented into oncology, infectious diseases, neurological disorders, cardiovascular diseases, other. Based on the end-user, the market segmented into clinical, commercial.
The analytical and testing services category is expected to hold a major share in the global Advanced Drug Delivery CDMO Market in 2025. Advanced drug delivery technologies such as liposomes, nanoparticles, implants, and long-acting injectables require sophisticated testing to ensure their performance, safety, and stability. These systems often exhibit complex release profiles, encapsulation efficiencies, and bioavailability parameters that must be validated using high-precision analytical methods. Analytical services are essential at every stage of the drug development lifecycle, from preformulation and clinical trials to regulatory submission and post-marketing surveillance. As a result, the Analytical and Testing Services segment holds the largest share in the advanced drug delivery CDMO market, as it plays a critical role in ensuring the quality, safety, regulatory compliance, and functional performance of increasingly complex drug delivery systems.
The North America Advanced Drug Delivery CDMO Market is expected to record the maximum market share in terms of revenue in the near future. The region's long-standing CDMO presence distinguishes the market in North America. The region is heavily invested in researching and developing biological medications, gene treatments, and other specialized pharmaceuticals. These complex compounds frequently necessitate specialized drug delivery devices, which drives demand for CDMO services. Along with this element, expanding partnerships between pharmaceutical firms and CDMOs providing a wide range of services are to blame for the region's leading market share globally. Due to the region's highly qualified workforce and low manufacturing and R&D costs, the Asia Pacific market is estimated to grow significantly over the course of the forecast period.
Recent Developments:
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD XXX Mn |
|
Revenue Forecast In 2034 |
USD XXX Mn |
|
Growth Rate CAGR |
CAGR of 5.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Service Type, Technology, Dosage Form, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
Catalent, Inc., Lonza Group AG, Kindeva Drug Delivery, MedPharm (merged with Tergus Pharma), WuXi AppTec, Hovione, Piramal Pharma Solutions, CordenPharma International, Divi’s Laboratories, Lifecore Biomedical, Recipharm AB, Syngene International, Thermo Fisher Scientific (Patheon), Aenova Group, Cellipoint Bioservices, Evonik Health Care, SHL Medical, Lubrizol Life Science, Acino International AG, Pharmathen, Phillips-Medisize (A Molex Company), Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Advanced Drug Delivery CDMO Market Snapshot
Chapter 4. Global Advanced Drug Delivery CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Advanced Drug Delivery CDMO Market Industry Trends
4.10. Global Advanced Drug Delivery CDMO Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Advanced Drug Delivery CDMO Market Segmentation 1: By Service Type, Estimates & Trend Analysis
5.1. Market Share by Service Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Service Type:
5.2.1. Formulation Development
5.2.2. Process Development and Scale-Up
5.2.3. Analytical and Testing Services
5.2.4. Manufacturing Services
5.2.5. Packaging and Device Development
5.2.6. Regulatory Support
Chapter 6. Advanced Drug Delivery CDMO Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share by Technology, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
6.2.1. Targeted Drug Delivery Systems
6.2.1.1. Nanoparticle-Based Systems
6.2.1.1.1. Lipid Nanoparticles (LNPs)
6.2.1.1.2. Polymeric Nanoparticles
6.2.1.1.3. Inorganic Nanoparticles
6.2.1.2. Biologics-Focused Targeting
6.2.1.2.1. Antibody-Drug Conjugates (ADCs)
6.2.1.2.2. Fusion Proteins & Peptide Conjugates
6.2.1.3. Stimuli-Responsive Systems
6.2.2. Controlled/Sustained-Release Technologies
6.2.3. Injectable Delivery Platforms
6.2.4. Pulmonary & Nasal Delivery Systems
6.2.5. Transdermal & Microneedle Delivery
6.2.6. Mucosal Delivery Methods
6.2.7. Implantable Delivery Devices
6.2.8. 3D-Printed Drug Delivery
Chapter 7. Advanced Drug Delivery CDMO Market Segmentation 3: By Dosage Form Industry, Estimates & Trend Analysis
7.1. Market Share by Dosage Form Industry, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Dosage Form Industry:
7.2.1. Injectables
7.2.2. Oral Solids
7.2.3. Topical & Transdermal
7.2.4. Implantables & Ocular
Chapter 8. Offline Advanced Drug Delivery CDMO Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
8.2.1. Oncology
8.2.2. Infectious Diseases
8.2.3. Neurological Disorders
8.2.4. Cardiovascular Diseases
8.2.5. Other (e.g., diabetes, ophthalmology, rare diseases)
Chapter 9. Advanced Drug Delivery CDMO Market Segmentation 5: By End-User, Estimates & Trend Analysis
9.1. Market Share by End-User, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
9.2.1. Clinical
9.2.2. Commercial
Chapter 10. Advanced Drug Delivery CDMO Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Advanced Drug Delivery CDMO Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.2.3. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.4. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.2.5. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.6. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3. Europe
10.3.1. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.3.3. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.4. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.3.5. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.6. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.4.3. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.4.4. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts Application, 2021-2034
10.4.5. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5. Latin America
10.5.1. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.5.3. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.4. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.5.5. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.6. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.6.3. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.4. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.6.5. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.6. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Catalent, Inc.
11.2.1.1. Business Overview
11.2.1.2. Key Service Type/Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Lonza Group AG
11.2.3. Kindeva Drug Delivery
11.2.4. MedPharm (merged with Tergus Pharma)
11.2.5. WuXi AppTec
11.2.6. Hovione
11.2.7. Piramal Pharma Solutions
11.2.8. CordenPharma International
11.2.9. Divi’s Laboratories
11.2.10. Lifecore Biomedical
11.2.11. Recipharm AB
11.2.12. Syngene International
11.2.13. Thermo Fisher Scientific (Patheon)
11.2.14. Aenova Group
11.2.15. Cellipoint Bioservices
11.2.16. Evonik Health Care
11.2.17. SHL Medical
11.2.18. Lubrizol Life Science
11.2.19. Acino International AG
11.2.20. Pharmathen
11.2.21. Phillips-Medisize (A Molex Company)
11.2.22. Others
Segmentation of Advanced Drug Delivery CDMO Market -
Advanced Drug Delivery CDMO Market, By Service Type
Advanced Drug Delivery CDMO Market, By Technology
Advanced Drug Delivery CDMO Market, By Dosage Form
Advanced Drug Delivery CDMO Market, By Application
Advanced Drug Delivery CDMO Market, By End-User
Advanced Drug Delivery CDMO Market, By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
